An impaired insulin-stimulated myocardial glucose metabolism is an alteration strongly correlated with whole-body insulin resistance and observed in patients with T2DM with or without coronary heart disease (CHD) or heart failure and in conditions at increased risk of T2DM, including prediabetes and metabolic syndrome [14–19]. Here, INS is linked to type 2 diabetes mellitus.